Determinants and prognosis of atrial fibrillation in patients with aortic stenosis

Franck Levy1, Dan Rusinaru2, Sylvestre Maréchaux3

  • 1Department of Cardiology, University Hospital Amiens, Amiens, France; INSERM U-1088, Jules Verne University of Picardie, Amiens, France.

Insights

Atrial fibrillation (AF) significantly increases mortality risk in patients with aortic stenosis (AS), regardless of treatment or disease severity. This finding highlights AF as a critical risk marker in AS management.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Epidemiology

Background:

  • Atrial fibrillation (AF) is common in patients with aortic stenosis (AS), with incidence rising with age.
  • AF is a known cardiovascular risk factor in the general population.

Purpose of the Study:

  • To investigate the prognostic significance of AF in patients with AS within a routine clinical practice setting.
  • To determine if AF impacts mortality risk in AS patients, considering different management strategies and disease characteristics.

Main Methods:

  • Analysis of 809 patients diagnosed with AS (aortic valve area <2 cm², normal ejection fraction ≥50%).
  • Patients were categorized into two groups: sinus rhythm (SR) and atrial fibrillation (AF) at enrollment.
  • Four-year all-cause mortality was assessed using multivariate analysis, with stratification for asymptomatic status, severe AS, and medical/surgical management.

Main Results:

  • The AF group (17.5% of patients) had a significantly higher 4-year all-cause mortality (60% ± 5%) compared to the SR group (24% ± 2%).
  • Multivariate analysis revealed AF as an independent predictor of mortality (adjusted HR 2.47, p=0.0001).
  • This association persisted in asymptomatic patients (aHR 2.31, p=0.002), severe AS patients (aHR 2.22, p=0.001), and those managed medically (aHR 2.52, p=0.0001).

Conclusions:

  • Atrial fibrillation is a major predictor of mortality in patients with aortic stenosis, irrespective of management strategy (medical or surgical) or disease severity.
  • AF serves as a strong risk marker in AS, crucial for clinical decision-making and patient risk stratification.
  • The presence of AF warrants careful consideration in the management of AS patients due to its significant impact on prognosis.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.2K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
466
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
910
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
459
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
410